News for Pfizer Stock (PFE)

7 Growth Stocks to Buy as We Head Into 2021

InvestorPlace • 11/19/20

What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data

Zacks Investment Research • 11/19/20

Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%

Zacks Investment Research • 11/19/20

What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?

Zacks Investment Research • 11/19/20

Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China

Business Wire • 11/19/20

A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should Know

The Motley Fool • 11/19/20

Results from Phase 3 CROWN Trial of Pfizer's LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine

Business Wire • 11/19/20

Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?

The Motley Fool • 11/19/20

BioNTech says vaccine approval possible in mid-December under ideal conditions

Reuters • 11/18/20

New Data Shows Higher Efficacy Rate for Pfizer and BioNTech Coronavirus Vaccine Candidate

The Motley Fool • 11/18/20

Pfizer Inc. (PFE) Management on 2nd Annual Wolfe Research Healthcare Conference (Transcript)

Seeking Alpha • 11/18/20

Here's What's Bumping BioNTech Stock Higher Today

The Motley Fool • 11/18/20

Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial

24/7 Wall Street • 11/18/20

Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?

InvestorPlace • 11/18/20

Pfizer, BioNTech Stocks Rise After Final Vaccine Update

Schaeffers Research • 11/18/20

Pfizer says analysis shows 3.8% of participants experienced fatigue

Reuters • 11/18/20

Pfizer's coronavirus shot is 95% effective

Business Insider • 11/18/20

Factbox: Development of Pfizer-BioNTech coronavirus vaccine

Reuters • 11/18/20

Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval

Business Insider • 11/18/20

Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks last quarter. He's been teasing a bet on the sector for more than 20 years

Business Insider • 11/18/20

Pfizer-BioNTech Plan Vaccine Emergency Use Filing Within Days After Final Analysis Confirm Efficacy, Safety

Benzinga • 11/18/20

Pfizer COVID-19 vaccine update: Final results shows it's 95% effective, too

Fast Company • 11/18/20

Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.

Business Insider • 11/18/20

Pfizer's COVID-19 vaccine 95% effective in final results, company to seek approval within days

Fox Business • 11/18/20

Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soon

Market Watch • 11/18/20